Actnova Secures $3M in Pre-Series A Funding to Fight Brain Disorders with AI
South Korean AI SaaS solution developer, Actnova, has secured KRW 3.3 billion ($3M) in pre-series A funding. The company focuses on treating brain disorders like dementia and Parkinson's disease using AI and web platform technologies.
Actnova develops AI-based technology for behavior analysis and visualization, automating behavioral testing processes in clinical and non-clinical fields. The funding round was led by Hana Ventures, with participation from A Ventures and Fast Ventures. Besides Hana Ventures, the financing round included investments from Korea Investment Partners and LB Investment.
Actnova plans to use the funds for global expansion, product launches, and collaborations with research institutes and pharmaceutical companies. The company aims to make a significant impact on the treatment of brain disorders.
Actnova's innovative use of AI and web platform technologies has attracted significant investment. With the secured funding, the company is well-positioned to expand globally and collaborate with key players in the field, potentially revolutionizing the treatment of brain disorders.
Read also:
- Web3 social arcade extends Pixelverse's tap-to-earn feature beyond Telegram to Base and Farcaster platforms.
- Over 5,600 Road Safety Violations Caught in Manchester Trial
- Trump praises the robustness of US-UK relations during his visit with Starmer at Chequers, showcasing the strong bond between the two nations.
- Navigating the Path to Tech Product Success: Expert Insights from Delasport, a Trailblazer in the Tech Industry
